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Abstract
Background: Nasopharyngeal carriage of Streptococcus pneumoniae is a determinant for invasive pneumococcal
disease, which often complicates homozygous sickle cell disease. Here, we determined the nasopharyngeal carriage
rate of S. pneumoniae in Ugandan children with homozygous sickle cell disease, who attended the outpatient
Sickle Cell Clinic at Mulago National Referral hospital in Kampala, Uganda.
Results: S. pneumoniae occurred in 27 of the 81 children with homozygous sickle cell disease (giving a carriage
rate of 33%, 27/81). Twenty three children were previously hospitalized of whom S. pneumoniae occurred in only
two (9%, 2/23), while among the 58 who were not previously hospitalized it occurred in 25 (43%, 25/58, c
2 = 8.8, p
= 0.003), meaning there is an association between high carriage rate and no hospitalization. Two children
previously immunized with the pneumococcal conjugate vaccine did not carry the organism. Prior antimicrobial
usage was reported in 53 children (65%, 53/81). There was high resistance of pneumococci to penicillin (100%, 27/
27) and trimethoprime-sulfamethoxazole (97%, 26/27), but low resistance to other antimicrobials. Of the 70 children
without sickle cell disease, S. pneumoniae occurred in 38 (54%, 38/70) of whom 43 were males and 27 females
(53% males, 23/43, and 56% females, 15/27).
Conclusion: Nasopharyngeal carriage of penicillin resistant pneumococci in Ugandan children with homozygous
sickle cell disease is high. While nasopharyngeal carriage of S. pneumoniae is a determinant for invasive
pneumococcal disease, pneumococcal bacteremia is reportedly low in Ugandan children with sickle cell disease.
Studies on the contribution of high carriage rates to invasive pneumococcal disease in these children will be
helpful. This is the first report on pneumococcal carriage rate in Ugandan children with sickle cell disease.
Background
Sickle cell anemia, also known as homozygous sickle cell
disease (genotype b
sb
s [1]) is prevalent in Uganda [2].
Invasive pneumococcal disease is one of the leading
complications of homozygous sickle cell disease (HbSS)
[3]. Patients with HbSS are more prone to pneumococ-
cal meningitis [4,5] and to pneumococcal septicemia
[6,7]. Globally, the incidence of invasive pneumococcal
disease in children with HbSS is 30- to 600-fold higher
than in individuals of comparable age and race without
HbSS; pneumococcal septicemia and meningitis are
important causes of death in HbSS patients, with case/
fatality rates of 15 to 35% [4,8-11].
There are varying reports of invasive pneumococcal
disease in sub-Saharan African children with HbSS; in
t h eD e m o c r a t i cR e p u b l i co fC o n g o ,S. pneumoniae was
the most frequent isolate from HbSS patients with bac-
teremia [2,12], and the organism was recovered from
blood cultures of all the eight HbSS-patients with pneu-
monia in Northern Nigeria [13]. However, three other
Nigerian studies [14-16] reported low prevalence of
pneumococcal bacteremia in patients with HbSS.
Further, S. pneumoniae bacteremia is reportedly very
low in Ugandan children with HbSS [17].
Nasopharyngeal carriage of S. pneumoniae is the
determinant for invasive pneumococcal disease particu-
larly in industrialized settings [18,19]; therefore,
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particularly in high risk groups such as HbSS patients.
While pneumococcal bacteremia in Ugandan children
with HbSS is low [17], pneumococcal carriage rates in
these children have not been determined, yet carriage
rates for healthy children are available (62% prevalence
[20]). Here we aimed to determine the nasopharyngeal
carriage rate of S. pneumoniae in Ugandan children with
HbSS attending the Sickle Cell Clinic at Mulago
National Referral Hospital in Kampala, Uganda.
Methods
Patient description and sampling
This study took place over a 6 month period from
December 2001 to May 2002. Eighty one children (51
males and 30 females, aged 8 months to 6 years, ascer-
tained from patient records) with severe HbSS, attending
the Sickle Cell Clinic at Mulago hospital in Kampala,
Uganda, were recruited. Of these, 23 were previously
admitted for treatment of low haemoglobin levels. All the
children frequently visited the sickle cell clinic, which
provides care to children confirmed with sickle cell ane-
mia in Uganda (see references [2] and [17]). The young-
est child was 8 months while the oldest was 6 years; the
median age was 2.8 years. All the children had symptoms
of severe HbSS disease based on clinical reports and
symptoms. Records indicated that the children were on
programmed routine visits to the clinic, although some
reported whenever complications developed. The diagno-
sis of HbSS was based on an FSA2 pattern upon haemo-
globin electrophoresis and characteristic haematology;
haemoglobin electrophoresis testing was performed ear-
lier on samples from these children and detected homo-
zygous sickle cell disease (HbSS).
Parents or guardians signed an informed consent form
and were interviewed on antimicrobial usage during the
preceding one month and on the history of pneumococ-
cal immunization (to determine their effects on recovery
of pneumococci). The data on antimicrobial usage was
verified by cross-checking with the information on pre-
scription forms presented by the attendants. Nasophar-
yngeal specimens (one sample per child) were obtained
by a paediatrician on duty using pre-packed sterile dis-
posable calcium alginate fiber tipped-aluminum applica-
tor swab. Children above 6 years were excluded
(because they are less colonized by pneumococci [21]),
as well as those who presented with severe ailments par-
ticularly pneumonia, and those who lacked consent from
parents/guardians. Seventy children (2-6 years) with no
history of HbSS from an outpatient ward were also
sampled (controls) to compare the pneumococcal car-
riage rates. Symptoms of HbSS were missing in control
subjects and they were considered not to have HbSS;
however, they presented with fever and diarrhea, for
which they sought care. For most children in Uganda,
HbSS symptoms usually manifest within 6 months to 1
year after birth (unpublished observations); hence we
excluded children less than 1 year among controls to
minimize including those with HbSS disease.
Culture and identification of S. Pneumoniae
Nasopharyngeal specimens were immediately transported
in Stuart’s transport medium to the laboratory and cul-
tured according to standard microbiological procedures.
Briefly, the specimens were inoculated onto 5% rabbit
blood agar plates and incubated for 24-48 h at 35-37°C
under 5% CO2. S. pneumoniae was identified based on
colony morphology, a-hemolysis and Gram staining and
confirmed based on optochin sensitivity and bile solubi-
lity. Antimicrobial susceptibility was performed with bac-
terial suspensions of turbidity equivalent to McFarland
0.5 with the following disks (Oxoid, UK): oxacillin, 1 μg;
erythromycin, 25 μg; ceftriaxone, 30 μg; chloramphenicol,
30 μg; trimethoprime-sulfamethoxazole, 23-75 μg; rifam-
picin, 5 μg; and perfloxacin, 17 μg. Interpretation for sen-
sitivity, intermediate or resistance was based on
guidelines from the Clinical and Laboratory Standards
Institute (CLSI). Controls included Staphylococcus aureus
ATCC 25923 and Escherichia coli ATCC 29522.
Ethical approval was obtained from the Mulago Hos-
pital Research and Ethics Committee, and the Faculty of
Medicine Research and Ethics Review Board.
Results and discussion
S. pneumoniae occurred in 27 of the 81 children with
HbSS (giving a nasopharyngeal carriage rate of 33%, 27/
81). Thus, in the current study a much higher S. pneu-
moniae carriage rate was found than in a previous
report from the USA in which prevalence was reported
to be 13% [3]. However, for healthy Ugandan children
without HbSS, Joloba et al, found a significantly higher
nasopharyngeal carriage rate (62%) [20]. Of the 23 pre-
viously hospitalized children, pneumococci occurred in
two (2/23, 9%). Fifty eight children had not been hospi-
talized before, of whom pneumococci occurred in 25,
meaning there is an association between high carriage
rate and no hospitalization (25/58, 43%, c2=8 . 8 ,p =
0.003). There was no major difference in carriage rates
between males and females (i.e., 35%, 18/33 males vs.
30%, 9/23 females). Of the 70 children without HbSS,
pneumococci occurred in 38 (54%, 38/70) of whom 23
were males (23/38, 61%) and 15 females (15/38, 39%).
Two children with HbSS had been immunized with a
conjugate pneumococcal vaccine and did not carry the
organism; pneumococcal immunization was not
reported among children without HbSS. Fifty three chil-
dren with HbSS reported antimicrobial usage (53/81,
65%, Table 1) while it was reported by 43 children
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used included penicillins, sulphomexazole-trimethoprim,
chloramphenicol and cephalexin (Table 1).
All isolates from children with HbSS were resistant to
penicillin (27/27, 100%) while those from children with-
out HbSS were intermediate (38/38, 100%). Resistance
to sulphomexazole-trimethoprim was also high for both
categories. However, the isolates from both groups were
sensitive to the other commonly used antimicrobials
(Table 2). These findings are similar to those of Joloba
et al, who found high rates of penicillin and sulphomex-
azole-trimethoprim resistant S. pneumoniae [20]. How-
ever in this study, the isolates from children with HbSS
were fully resistant to penicillin while those in the pre-
vious study were intermediate. The lower carriage rate
and increased antimicrobial resistance to penicillin in
the current study may be attributed to the common
usage of penicillin in children with HbSS [20]. Neverthe-
less, there is no report on penicillin prophylaxis among
sickle cell children in Uganda but the drug is widely
prescribed [2] and can be purchased over the counter
without prescription. Further, while penicillin prophy-
laxis in Uganda is recommended for children with
HbSS, it is not followed in principle since the drug is
not free and some parents/guardians cannot afford it.
Usually parents with the means to do so can easily
obtain the drug over the counter. However, when the
children are unwell the drug will almost certainly be
taken, meaning that use of penicillin in this population
is generally symptomatic rather than prophylactic. High
carriage rates of antimicrobial resistant strains were also
found in Zambia (Pneumococcus was reported in 71.9%
of the children [22]); however, 12.7% of the strains were
resistant to penicillin [22]. The reason for the difference
in resistance rates between Uganda and Zambia is likely
due to law enforcement practices on antimicrobial
usage.
Antimicrobial usage during the previous month did
not significantly affect nasopharyngeal carriage rates (p
= 0.93). However in previous studies, prior antimicrobial
usage reduced the nasopharyngeal carriage of S. pneu-
moniae [23]. Of the 27 HbSS children from whom S.
pneumoniae was recovered, nine had not used antimi-
crobials; seven had used sulphomexazole-trimethoprim;
five penicillin; one amoxicillin-cloxacillin; one Augmen-
tin; two amoxicillin + sulphomexazole-trimethoprim;
one ampicillin; one chloramphenicol and none used
cephalexin. Of the 54 HbSS children from whom S.
pneumoniae was not recovered, 19 had not used antimi-
crobials; 12 had used sulphomexazole-trimethoprim;
three penicillin; four amoxicillin-cloxacillin; three Aug-
mentin; four amoxicillin + sulphomexazole-trimetho-
prim; five ampicillin; two chloramphenicol and one
cephalexin. Of the 70 children without HbSS, 27 had
not used any antimicrobial; 27 had taken sulphomexa-
zole-trimethoprim; 12 penicillin; three chloramphenicol;
and one amoxicillin + sulphomexazole-trimethoprim.
Despite the high nasopharyngeal carriage (which is a
determinant for invasive pneumococci [18]), there is a
puzzling discrepancy of high carriage rates with low
rates of invasive pneumococcal disease in sub-Saharan
Africa (see references [1,17]). Kizito et al [17] reported a
significantly low rate of pneumococcal bacteremia in
Ugandan children with sickle cell disease (6%, 3/47)
Table 1 Antimicrobial usage in Ugandan children with HbSS
Antimicrobial None SXT Pen Amo/Clox Aug Amo/SXT Amp Chl Cep
S. pneumoniae carriers 27 97 5 11 2 1 1 -
Non carriers 54 19 12 4 43 4 5 2 1
TOTAL 81 28 19 9 54 6 6 3 1
SXT, trimethoprime-sulfamethoxazole; Pen, penicillin; Amo, amoxicillin; Clox, cloxacillin; Aug, Augmentin; Amo, amoxicillin; Amp, ampicillin; Chl, chloramphenicol;
Cep, cephalexin; -, Not detected
Table 2 Antimicrobial susceptibility patterns of pneumococci from Ugandan children with HbSS
HbSS No HbSS
Antimicrobial Susceptible (%) Intermediate (%) Resistant (%) Susceptible (%) Intermediate (%) Resistant (%)
Penicillin - - 27 (100) - 38 (100) -
SXT - 1 (3) 26 (97) - 5 (7) 18 (26)
Chloramphenicol 26 (97) - 1 (3) 16 (23) 2 (3) 5 (7)
Erythromycin 26 (97) - 1 (3) 19 (27) 2 (3) 2 (3)
Rifampin 27 (100) - - 23 (33) - -
Cefriaxone 27 (100) - - 23 (33) - -
Perfloxacin 17 (100) - - 23 (33) - -
-, Not detected
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bacteremia in Nigerian children [1,14-16]. These could
be a consequence of uncontrolled antimicrobial usage
particularly in the urban populations in those countries.
However, the high rates of pneumococcal bacteremia in
children with/without sickle cell disease in neighboring
Kenya [6], the Gambia [24], Ghana [25], and Mozambi-
que [26] cast doubt on previous reports with low rates
of invasive pneumococcal disease. Since laboratory facil-
ities in sub-Saharan Africa are generally not well estab-
lished [6,27], surveillance can be challenging particularly
for fastidious organisms such as the pneumococcus.
Moreover, certain invasive pneumococcal serotypes are
difficult to detect in the nasopharynx. Further, since the
largest population based retrospective study of bactere-
mia in Kenyan children with HbSS revealed high inci-
dence of invasive pneumococci [6], contrary to current
reports [1,17], invasive pneumococcal disease may not
be uncommon in sub-Saharan African children with
HbSS.
One major limitation in this study was failure to
determine the prevailing serotypes among HbSS
patients, which we presume would most likely be similar
to those described by Joloba et al (i.e., serogroups 6, 9,
14, 19, and 23) [20]. Further, due to limited resources,
we were unable to extend the study beyond 6 months,
and we did not confirm control subjects for the absence
of HbSS disease but relied on absence of HbSS symp-
toms. This being the first report of nasopharyngeal car-
riage rate of pneumococci from Ugandan children with
sickle cell disease, we hope that future studies will put
these in consideration.
Conclusions
A high carriage rate of penicillin resistant S. pneumoniae
has been found in Ugandan children with HbSS. This
rate is similar to or higher than those in settings where
nasopharyngeal carriage is the determinant for invasive
pneumococcal disease in HbSS patients [3]. A puzzling
finding in previous studies is the low level of pneumo-
coccal bacteremia in Ugandan children with HbSS [17].
Accordingly, the usefulness of pneumococcal prophy-
laxis in Ugandan children with HbSS has been debated
[17]. Since pneumococci are leading causes of childhood
and adult bacteremia/mortality in sub-Saharan Africa
[26,28-30], further studies are necessary to resolve the
discrepancy between high nasopharyngeal carriage rates
of pneumococci and invasiveness.
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